Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

计划入组 34 人 · 首次发布于 2010 年 11 月 24 日

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

计划入组 2,340 人 · 首次发布于 2019 年 3 月 1 日

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

计划入组 2,380 人 · 首次发布于 2019 年 2 月 26 日

Haemagglutinin-strain B (Victoria-like)(Afluria Tetra, FluLaval Tetra, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra)

Influenza B virus Victoria lineage haemagglutinin, recombinant

Influenza virus type B (Victoria)(FluMist Quadrivalent)

Victoria University

Canada

Ambulance Victoria

Australia

University of Victoria

Canada

Sino Biological Launches Antigens for 2026-2027 Influenza Vaccine Strains Following WHO Recommendations

Moderna's Combination Flu-COVID Vaccine Shows Superior Immune Response in Phase 3 Trial

MindWalk Identifies Universal Functional Constraint Across Influenza Viruses Using AI Technology